At Thalocan Research Innovations we pride ourselves on improving the quality of our trainings through creative collaboration with clinical researchers. Our team of graphic designers and animators provide the most effective and state-of-the-art visual support to meet all the needs of your customized training. Find out more at https://www.thalocan.com/trainings/
Thalocan Research Innovations and AGAPE Strategic Solutions of Maryland, LLC align on the significance of including patient perspectives and the social determinant of health in clinical research that includes the input of all relevant populations. Building trust in the engagement process and utilizing patient-centered tools to capture the accuracy of clinician and patient-reported outcomes help…
DetailsThalocan Research Innovations Creative Director, Paul Stroili discusses our recent company conference in Los Angeles, recognizing just some of the many who share our mission of revolutionizing the clinical assessment of dermatological diseases.
We are grateful to Dr. John Ingram for his comments regarding Thalocan’s new Lesion Area Mapping Assistant. Learn more about LAMA by clicking here. In addition, Dr. Amit Garg describes how LAMA can help overcome the time-consuming hurdles encountered in lesion counting and assessment. See our discussion with Dr. Garg by clicking here.
DetailsOur CEO, Eric Zudak will be representing Thalocan Research Innovations at The EADV Congress, the globally recognized international meeting focused on dermatology and venereology. We always learn so much, in fact – our most innovative product was conceived during an expert presentation at EADV 2023 in Berlin! That product, LAMA, (https://www.thalocan.com/lama/) is now study-ready for…
DetailsThalocan Research Innovations is excited to launch our YouTube channel, an ever-expanding resource of news, technology, webinars and conversations with global leaders supporting the clinical assessment of dermatological diseases. We are grateful to all who have joined us and will continue to work with us in building cutting-edge tools designed to enhance every stage of…
DetailsAugust is observed as hair loss awareness month, and we here at Thalocan Research Innovations are proud to join organizations like the National Alopecia Areata Foundation in raising awareness and drawing attention to this significant challenge that can impact a person’s health, confidence and overall well-being. Recently, we partnered with Arash Mostaghimi, MD, MPA, MPH…
Details“The current set up for HS lesion counting in clinical trials and routine practice is far from ideal. Counting multiple lesions in multiple body sites takes time and there is high risk for error. Thalocan’s Lesion Area Mapping Assistant Trial enables sponsors to undertake quality control from the images and site personnel can assess images…
DetailsThalocan Research Innovations has partnered with Arash Mostaghimi, MD, MPA, MPH to develop a comprehensive training for the BETA and BELA to accompany The Severity of Alopecia Tool (SALT), training for a robust and high quality Alopecia assessment curriculum. Our mission is to support clinical raters with a clear understanding of the scoring criteria for…
DetailsThe fourth in our series of Conversations with Portia Combow and living with HS. Thalocan Research Innovations CEO Eric Zudak and Portia discuss the roadblocks she’s encountered with clinical studies. Watch the full webinar/conversation at www.thalocan.com/webinars/.
